版本:
中国

BRIEF-Nabriva Therapeutics provides business and development update and reports 2016 financial results

March 24 Nabriva Therapeutics AG

* Nabriva Therapeutics provides business and development update and reports 2016 financial results

* Nabriva Therapeutics AG- Expect to complete patient enrollment for leap 2 in Q4 of 2017

* Nabriva Therapeutics AG- Anticipate receiving top-line data for leap 2 in Q1 of 2018

* Nabriva Therapeutics AG - Expect year-end balance will be sufficient to fund our operating expenses and capital expenditures at least into Q2 of 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐